Groundbreaking Study of Laser Treatment for Breast Cancer Now Has 11 Active Trial Sites in United States and United Kingdom

CHICAGO - Novian Health, developer of Novilase® Breast Therapy, announced today that Walter Reed National Military Medical Center (Bethesda, Md.) is now a participating study site in the BR-002 Novilase Clinical Trial. The multi-center study is evaluating the effectiveness of Novilase Breast Therapy as an alternative to lumpectomy surgery for the treatment of small, early-stage breast cancers. Novian Health has already received FDA clearance for the use of Novilase Breast Therapy as an alternative to surgery for the treatment of benign breast tumors (fibroadenomas).

"Patients appreciate taking part in this clinical trial because they know they're contributing to the possible improvement of breast cancer treatment in the future," said Barbara Schwartzberg, M.D. "Because our enrollees have stepped forward, women someday may be able have their tumors treated as a convenient outpatient procedure, instead of an invasive surgery with anesthesia and a long recuperation."


Dr. Schwartzberg is principal investigator of the BR-002 Novilase Clinical Trial. She is also the principal investigator at Rose Medical Center (Denver, Col.), one of the 11 breast centers in the BR-002 breast cancer study.

Known as "the Nation's Medical Center," Walter Reed National Military Medical Center in Bethesda, Maryland serves military families, active duty personnel, returning war heroes, veterans, and the nation's leaders.

Col. Craig D. Shriver, M.D., U.S. Army, is the principal investigator for the BR-002 Novilase Clinical Trial at Walter Reed, where he directs the institution's Murtha Cancer Center.

In addition to Walter Reed, ten other sites have been enrolling patients for the early-stage breast cancer study. The sites include:

* Rose Medical Center - Rose Breast Center (Denver, Col.)
Principal Investigator: Dr. Barbara Schwartzberg

* Alexian Brothers Health System - St. Alexius Breast Care Center (Bartlett, Ill.)
Principal Investigator: Dr. Robert Maganini

* Broomfield Hospital - Mid Essex Hospital NHS Trust (Chelmsford, UK England)
Principal Investigator: Mr. Simon Smith

* Wheaton Franciscan Health System (Milwaukee, Wisc.)
Principal Investigator: Dr. Hanadi Bu-Ali

* Southmead Hospital - North Bristol NHS Trust (Bristol, UK England)
Principal Investigator: Dr. Michael Shere

* Advocate Lutheran General Hospital - Caldwell Breast Center (Park Ridge, Ill.)
Principal Investigator: Dr. Heidi Memmel

More HCB News